Business Wire3d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
ophthalmologytimes18h
Researchers warn of eye risks from over-the-counter cosmetics
Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products ...
Medscape4d
Medication Review for the 10-Minute Consultation: The NO TEARS Tool
Synchronization of treatments is important to reduce wastage. Overlap between the areas of NO TEARS enables adaptation to individual consultation style. For instance, the need for bone protection ...
bjo.bmj4d
Retinal age gap as a predictive biomarker for mortality risk
Aim To develop a deep learning (DL) model that predicts age from fundus images (retinal age) and to investigate the association between retinal age gap (retinal age predicted by DL model minus ...